Trial Profile
Clinical Trials Insight: 700028053
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2009
Price :
$35
*
At a glance
- Drugs Avosentan (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- 01 Nov 2007 New trial record.